Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Flot.bio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Flot.bio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]

1:07:40
 
Share
 

Manage episode 513380853 series 3470295
Content provided by Flot.bio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Flot.bio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Hot on the heels of CUTISS’ $60M Series C round, we catch up once more with CEO and co-founder Daniela Marino. We chat about the company’s mission to develop an engineered tissue therapy to reduce the need for skin grafts in patients with severe burns. She also explains the decentralization of tissue manufacturing with automation and the need for perseverance as a founder and CEO.

---This episode is sponsored by CUTISS, the only TechBio company in the advanced clinical stage of developing skin tissue therapies. Learn how you can support CUTISS on its path to Series C success: https://bit.ly/flotbio-cutiss---

⭐️ ABOUT THE SPEAKER

In 2023, Daniela Marino was named as one of the 30 Rising Leaders in the healthcare industry, thanks to the impact of CUTISS, the company she co-founded as a spin-off from the University of Zurich. Here, she and her team have made waves for people suffering from severe skin injuries and defects through regenerative medicine, tissue engineering, and skin pigmentation.

🔗 LINKS MENTIONED

📜 TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/daniela-marino-cutiss-tissue-engineering/

💸 DONATE

We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme

⭐️ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!

🫶 FOLLOW US

🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

🎙️ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.

⏰ TIMESTAMPS

  • [00:00:00] Intro-
  • [00:02:31] Investors in CUTISS’ Series C round
  • [00:06:45] Expanding a hospital collaboration
  • [00:08:34] Decentralized manufacturing drive
  • [00:11:50] Tissue therapeutics vs skin grafts
  • [00:24:35] Reimbursement and health economics
  • [00:38:39] CUTISS’ partnering and exit options
  • [00:47:54] Automation and artificial intelligence
  • [00:56:32] Europe can show its strength in biotech
  • [00:58:52] Daniela Marino answers quick-fire questions
  continue reading

43 episodes

Artwork
iconShare
 
Manage episode 513380853 series 3470295
Content provided by Flot.bio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Flot.bio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Hot on the heels of CUTISS’ $60M Series C round, we catch up once more with CEO and co-founder Daniela Marino. We chat about the company’s mission to develop an engineered tissue therapy to reduce the need for skin grafts in patients with severe burns. She also explains the decentralization of tissue manufacturing with automation and the need for perseverance as a founder and CEO.

---This episode is sponsored by CUTISS, the only TechBio company in the advanced clinical stage of developing skin tissue therapies. Learn how you can support CUTISS on its path to Series C success: https://bit.ly/flotbio-cutiss---

⭐️ ABOUT THE SPEAKER

In 2023, Daniela Marino was named as one of the 30 Rising Leaders in the healthcare industry, thanks to the impact of CUTISS, the company she co-founded as a spin-off from the University of Zurich. Here, she and her team have made waves for people suffering from severe skin injuries and defects through regenerative medicine, tissue engineering, and skin pigmentation.

🔗 LINKS MENTIONED

📜 TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/daniela-marino-cutiss-tissue-engineering/

💸 DONATE

We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme

⭐️ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!

🫶 FOLLOW US

🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

🎙️ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.

⏰ TIMESTAMPS

  • [00:00:00] Intro-
  • [00:02:31] Investors in CUTISS’ Series C round
  • [00:06:45] Expanding a hospital collaboration
  • [00:08:34] Decentralized manufacturing drive
  • [00:11:50] Tissue therapeutics vs skin grafts
  • [00:24:35] Reimbursement and health economics
  • [00:38:39] CUTISS’ partnering and exit options
  • [00:47:54] Automation and artificial intelligence
  • [00:56:32] Europe can show its strength in biotech
  • [00:58:52] Daniela Marino answers quick-fire questions
  continue reading

43 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play